Johnson & Johnson Applies For Emergency Use Authorization For COVID-19 Vaccine
The company's vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines already in use in the U.S.
A third coronavirus vaccine candidate has requested emergency use authorization from the Food and Drug Administration. Johnson & Johnson submitted its application Thursday for the company's single-dose inoculation.
